Bio-Rad Laboratories, Inc. Class A Common Stock vs FTAI Aviation Ltd — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while FTAI Aviation Ltd trades at $228.5 (market cap $23.17B). The key difference: FTAI Aviation Ltd is far larger — about 2.5× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and FTAI Aviation Ltd pays a 0.89% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | FTAI | |
|---|---|---|
Market Cap | $9.43B | $23.17B |
Sector | Health | Industrials |
52-Week High | $356.25 | $310.04 |
52-Week Low | $241.71 | $140.40 |
Enterprise Value | $9.18B | $26.29B |
Dividend Yield | — | 0.89% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →